3-pyridin-4-yl-N-[(1R)-1-(1,3-thiazol-2-yl)ethyl]-1,2-dihydroimidazo[4,5-f]indazole-6-carboxamide
C19H15N7OS — CID 138573612
Data last refreshed: (MolForge compound catalog, from PubChem)
About 3-pyridin-4-yl-N-[(1R)-1-(1,3-thiazol-2-yl)ethyl]-1,2-dihydroimidazo[4,5-f]indazole-6-carboxamide
3-pyridin-4-yl-N-[(1R)-1-(1,3-thiazol-2-yl)ethyl]-1,2-dihydroimidazo[4,5-f]indazole-6-carboxamide (PubChem CID 138573612) has the molecular formula C19H15N7OS and a molecular weight of 389.44 g/mol. Its IUPAC name is 3-pyridin-4-yl-N-[(1R)-1-(1,3-thiazol-2-yl)ethyl]-1,2-dihydroimidazo[4,5-f]indazole-6-carboxamide.
Molecular Properties
| Compound Name | 3-pyridin-4-yl-N-[(1R)-1-(1,3-thiazol-2-yl)ethyl]-1,2-dihydroimidazo[4,5-f]indazole-6-carboxamide |
|---|---|
| PubChem CID | 138573612 |
| Molecular Formula | C19H15N7OS |
| Molecular Weight | 389.44 g/mol |
| Exact Mass | 389.11 |
| IUPAC Name | 3-pyridin-4-yl-N-[(1R)-1-(1,3-thiazol-2-yl)ethyl]-1,2-dihydroimidazo[4,5-f]indazole-6-carboxamide |
| SMILES | C[C@@H](NC(=O)c1nc2cc3[nH][nH]c(-c4ccncc4)c3cc2n1)c1nccs1 |
| InChI | InChI=1S/C19H15N7OS/c1-10(19-21-6-7-28-19)22-18(27)17-23-14-8-12-13(9-15(14)24-17)25-26-16(12)11-2-4-20-5-3-11/h2-10,25-26H,1H3,(H,22,27)/t10-/m1/s1 |
| InChIKey | OVYUMMRKQDGIQX-SNVBAGLBSA-N |
| XLogP | 3.45 |
| TPSA | 112.24 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 28 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 389.44 |
| LogP ≤ 5 | 3.45 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 138573612 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.